PT-141 + Oxytocin Nasal Spray for Intimacy, Arousal & Emotional Connection Support

Key Benefits

Sexual Wellness Research

PT-141 (Bremelanotide) has been extensively studied for its potential role in supporting sexual desire and arousal in both men and women. Unlike medications that primarily affect blood flow, PT-141 acts on melanocortin receptors within the central nervous system involved in sexual response.

Emotional Connection & Bonding

Oxytocin has been researched for its involvement in trust, empathy, emotional bonding, and social connection. When administered intranasally, oxytocin has been investigated for its effects on pathways associated with interpersonal interaction and emotional processing.

Complementary Mechanisms

The combination of PT-141 and oxytocin has attracted research interest due to their complementary mechanisms of action. PT-141 primarily targets desire and arousal through melanocortin receptor activation, while oxytocin has been investigated for supporting emotional connection and intimacy.

Male & Female Research Interest

Research involving both compounds has explored potential applications in male and female sexual wellness, relationship dynamics, intimacy, and behavioural neuroscience. Individual responses may vary.

Product Overview

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist that has been studied for its effects on sexual desire and arousal through central nervous system pathways.

Oxytocin is a naturally occurring neuropeptide involved in social bonding, emotional regulation, and interpersonal connection.

This combination has been investigated in research settings for its potential to support desire, intimacy, emotional wellbeing, and social interaction through distinct yet complementary neurological pathways.

Responses vary significantly between individuals, and onset, duration, and perceived effects may differ depending on individual sensitivity.

Why Choose Our PT-141 + Oxytocin Nasal Spray?

Pre-mixed and ready to use

No reconstitution required. Formulated in a sterile solution for convenience and ease of administration.

Consistent dosing per spray

Designed to deliver approximately 100mcg PT-141 + 50mcg Oxytocin per spray for accurate and repeatable dosing. 1 spray per dose = 100 total doses per bottle.

Research-grade formulation

Manufactured using high-purity ingredients and prepared for stability and product integrity.

Convenient nasal spray bottle

Compact, easy-to-use design suitable for controlled dispensing and secure storage.

Typical Research Dosing

Typical Research Dose: 1-4 sprays per administration depending on the research protocol.

Research Timing: PT-141 has commonly been investigated when administered approximately 30 minutes to several hours before research sessions. Oxytocin research protocols vary, with timing dependent on the intended area of investigation.

Reported Research Areas: Sexual desire, arousal, intimacy, emotional bonding, relationship dynamics, social cognition, trust, empathy, and behavioural neuroscience.

Administration Note: Spray into the nostril while breathing in gently. Avoid sniffing forcefully after administration to help maximise nasal absorption.

Nasal Administration Tips

• Prime with 2–3 pumps before first use
• Alternate nostrils for each spray
• Tilt head forward, aim at outer nostril wall
• Wait 30–60s between sprays (same nostril)
• Gentle breath in, don’t sniff hard